This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Innovations of Tatsushi Kodama
Introduction
Tatsushi Kodama is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of RET inhibitors. With a total of 3 patents to his name, his work has the potential to impact cancer treatment significantly.
Latest Patents
One of his latest patents is focused on CLAUDIN-6 binding molecules and their uses. This patent describes a compound represented by a specific general formula, which acts as a RET inhibitor. The compound can be utilized as an agent for the prevention or treatment of disorders, including cancers and cancer metastasis that involve mutations in RET.
Career Highlights
Tatsushi Kodama is currently employed at Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work there has allowed him to explore innovative solutions in cancer treatment, contributing to the advancement of medical science.
Collaborations
He has collaborated with notable colleagues, including Toshiyuki Tsukaguchi and Hiroshi Sakamoto. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.
Conclusion
Tatsushi Kodama's contributions to the field of pharmaceuticals, particularly through his patents and collaborations, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and medical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile